MAPK1 and melanoma: To further investigate the role of the MEK-ERK pathway in BPF-induced cell death, we established K562 cells stably expressing a constitutively active mutant of BRAF (BRAFV600E), which was previously shown to be expressed in melanomas and induced the constitutive activation of its downstream MEK-ERK pathway [24].